Wrap Text
Quantum Leap Energy LLC completes the acquisition of One 30 Seven Inc. assets
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
QUANTUM LEAP ENERGY LLC COMPLETES THE ACQUISITION OF ONE 30 SEVEN INC.
ASSETS TO ADVANCE SOLUTIONS FOR THE PROCESSING OF WATER-SOLUBLE NUCLEAR
WASTE
- Quantum Leap Energy LLC plans to utilize technology acquired from One 30 Seven to
develop Creber Units to process water-soluble nuclear waste by accelerating beta decay of
radioactive waste, such as Cesium-137 and Strontium-90.
- There are currently 390,000 Metric Tons of radioactive waste globally, of which over
90,000 Metric Tons sit in the United States. [1]
- The total estimated liability for the Department of Energy failing to dispose of commercial
spent fuel was estimated at $44.5 billion in 2024, not including funds already paid out. [2]
- After this acquisition, Quantum Leap Energy intends to operate in several critical segments
of the nuclear fuel cycle, including Conversion, Deconversion, Enrichment, and Nuclear
Waste processing.
WASHINGTON, October 23, 2025 (GLOBE NEWSWIRE) –ASP Isotopes, Inc. NASDAQ: ASPI ("ASP
Isotopes" or the "Company") today announced that its subsidiary, Quantum Leap Energy LLC
("Quantum Leap Energy" or "QLE"), an advanced nuclear fuels company dedicated to the development
of technology and processes across critical segments of the nuclear fuel cycle, has completed the
purchase of certain assets from One 30 Seven Inc., a Canadian company engaged in the business of
researching and developing decontamination solutions for water-soluble nuclear waste, particularly
radioactive waste from radioactive materials from nuclear power plants, radiopharmaceuticals, and
military sources.
Quantum Leap Energy acquired substantially all of the assets of One 30 Seven, including an
international patent application and its related rights for a system and method for treating radioactively
contaminated water. Quantum Leap Energy also engaged B-Con Engineering Inc., a company affiliated
with One 30 Seven, to develop water-soluble nuclear waste decontamination solutions based on the
acquired patent that process water-soluble nuclear waste by accelerating beta decay of radioactive
waste, such as Cesium-137 and Strontium-90. The goal of the acquisition of One30Seven is to increase
the vertical integration of QLE's business in the nuclear fuel cycle.
Currently, the Department of Energy is responsible for managing all nuclear waste created by
commercial and public reactors and pays a processing fee to current reactor owners to store the fuel
on behalf of the Department of Energy. The total estimated liability for the Department of Energy failing
to dispose of commercial spent fuel was estimated at $44.5 billion in 2024, not including funds already
paid out. [2]
It is estimated that there are currently 390,000 Metric Tons of radioactive waste globally. [1] Roughly
3% of the total nuclear waste volume is considered High-Level Waste (HLW). HLW, although a small
amount of total volume contains 95% of the radioactivity in nuclear waste. [1] Using the technology
acquired from One30Seven we believe QLE will be able to develop proprietary nuclear waste
decontamination solutions called Creber Units that accelerate the beta decay of this HLW and rapidly
convert these long half-life isotopes into stable isotopes. The reduction of HLW reduces radioactive
impact on the environment and reduces the liability of storing nuclear waste. The removal of HLW also
allows for other non-HLW isotopes to be utilized for recycling and reprocessing in nuclear reactors.
The Creber Unit solutions come in four planned sizes (Micro, Mini, Midi, and Maxi sizes) and are
designed to allow for a modular approach and projected appropriate capital spending commitments and
shorter timelines to revenue generation. The Creber Unit solutions allow for a mobile solution as well
facilitating emergency response to nuclear waste situations.
QLE's first targeted nuclear waste isotope for the Creber unit will be Cesium-137, which decays into
stable Barium-137. The use of high-purity Barium-137 is emerging as a critical enabler of ion-trap
quantum computing, one of the leading approaches to building large-scale quantum machines.
Processing Nuclear Waste is considered to be a highly regulated process and will require a regulatory
review in any country in which QLE operates to begin testing its technology. This includes working with
the Nuclear Regulatory Commission (NRC), Department of Energy (DOE), Nuclear Waste Services
(NWS), and other global regulators.
Commenting on the Combination, Ryno Pretorius, CEO of Quantum Leap Energy, said:
"This acquisition represents a transformative effort to tackle the global challenge of nuclear waste,
harnessing the expertise of Brian Creber and his team to develop the Creber Unit solutions for water-
soluble nuclear waste processing over the next eighteen months. This initiative promises to reduce the
environmental burden of the vast quantities of radioactive waste worldwide, particularly high-level
waste, by advancing solutions that could stabilize hazardous isotopes, thereby safeguarding
ecosystems and public health for generations to come. Through collaboration with regulatory bodies
and the application of innovative technology, this partnership aims to alleviate the economic and
ecological pressures faced by entities like the U.S. Department of Energy, fostering a sustainable future
on a global scale."
Transaction Overview
Effective October 21, 2025, Quantum Leap Energy LLC (QLE) acquired substantially all assets of
One30Seven Inc., a Canadian company specializing in decontamination solutions for radioactive waste
from nuclear power plants, radiopharmaceuticals, and military sources. The assets include intellectual
property assets, such as an international patent application and its related rights for a system and
method to treat radioactively contaminated water. This acquisition is intended to advance the
development of Creber Micro, Mini, Midi, and Maxi Units and allow QLE to offer Nuclear Waste
processing solutions.
The upfront purchase price for the assets is comprised of a cash payment of $150,000 and 266,113
shares of ASPI common stock (determined by dividing $2,850,000 by a 30-day volume-weighted
average price (VWAP) of ASPI common stock). Under the terms of the purchase agreement, One 30
Seven has the opportunity to earn additional consideration as follows: (i) upon the completion of a
validated and operational Creber Mini Unit, an amount equal to $6,000,000, which is potentially payable
in cash, shares of ASPI's common stock or shares of QLE's common equity; and (ii) upon the completion
of a validated and operational Creber Midi Unit or Maxi Unit, an amount equal to $11,000,000, which is
potentially payable in cash, shares of ASPI's common stock or shares of QLE's common equity.
QLE also entered into a consulting agreement with B-Con Engineering Inc., led by inventor Brian
Creber, to develop and validate the functional operation of a Creber Mini Unit at an estimated cost of
$4.5 million over 18 months, followed by either a Midi or Maxi Unit at approximately $12.5-13 million
over another 18 months. QLE has agreed to fund the project through quarterly advances, with
acceptance testing and monthly reporting to ensure milestones are met.
QLE also entered into a royalty agreement with One30Seven pursuant to which QLE agreed to pay a
6.0% royalty on net revenues from product sales or licensing for 15 years per product, starting from the
first commercial sale. The royalty agreement will terminate if the commercialization of a Creber Unit is
not achieved by the fourth anniversary of closing.
[1] https://world-nuclear.org/information-library/nuclear-fuel-cycle/nuclear-waste/radioactive-waste-
management
[2] https://www.ans.org/news/article-6587/us-spent-fuel-liability-jumps-to-445-billion/
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are
neither historical facts nor assurances of future performance. Instead, they are based only on our
current beliefs, expectations, and assumptions regarding the future of our business, future plans and
strategies, projections, anticipated events and trends, the economy, and other future conditions.
Forward-looking statements can be identified by words such as "goal", "target", "believes," "plans,"
"anticipates," "expects," "aims", "intends", "estimates," "projects," "will," "may," "might," "seeks", "sees",
"should," "would," "expect," "positioned," "strategy," and words of a similar nature. Examples of forward-
looking statements include, among others but are not limited to, statements relating to the completion
of the development of nuclear fuel processing solutions in the anticipated timeframe or at all, the
integration of QLE's and One 30 Seven's businesses and the ability to recognize the anticipated
synergies and benefits of the transactions, the anticipated market demand for QLE's future nuclear fuel
processing solutions, and the company's discussions with nuclear regulators, and statements we make
regarding expected operating results, such as future revenues and prospects from the potential
commercialization of isotopes, future performance under contracts, and our strategies for product
development, engaging with potential customers, market position, and financial results. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and
changes in circumstances that are difficult to predict, many of which are outside our control. Our actual
results, financial condition, and events may differ materially from those indicated in the forward-looking
statements based upon a number of factors. Forward-looking statements are not a guarantee of future
performance or developments. You are strongly cautioned that reliance on any forward-looking
statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any
of these forward-looking statements. There are many important factors that could cause our actual
results and financial condition to differ materially from those indicated in the forward-looking statements,
including, but not limited to, risks related to the factors disclosed in Part I, Item 1A. "Risk Factors" of the
company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and any
amendments thereto and in the company's subsequent reports and filings with the U.S. Securities and
Exchange Commission. Any forward-looking statement made by us in this press release is based only
on information currently available to us and speaks only as of the date on which it is made. We
undertake no obligation to publicly update any forward-looking statement, whether as a result of new
information, future developments or otherwise. No information in this press release should be
interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-
looking statements herein are qualified by reference to the cautionary statements set forth herein and
should not be relied upon.
Contacts
Jason Assad– Investor relations
Email: Jassad@aspisotopes.com
Telephone: 561-709-3043
23 October 2025
Sponsor
Valeo Capital Proprietary Limited
Date: 23-10-2025 02:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.